Biocept Inc (BIOCQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 589 | 673 | -913 | 1,007 | 5,819 |
| Cost of Goods | 2,550 | 3,028 | 4,307 | 5,776 | 8,023 |
| Gross Profit | -1,961 | -2,355 | -5,220 | -4,769 | -2,204 |
| Operating Expenses | 4,703 | 4,771 | 4,875 | 6,164 | 7,708 |
| Operating Income | -6,114 | -7,098 | -9,788 | -10,157 | -9,889 |
| Interest Expense | 50 | 46 | 48 | 52 | 155 |
| Other Income | 2,533 | 0 | 3 | 84 | 0 |
| Pre-tax Income | -3,631 | -7,144 | -9,833 | -10,125 | -10,044 |
| Net Income Continuous | -3,631 | -7,144 | -9,708 | -10,125 | -10,044 |
| Net Income | $-3,631 | $-7,144 | $-9,708 | $-10,125 | $-10,044 |
| EPS Basic Total Ops | -3.50 | -12.31 | -17.01 | -18.02 | -17.82 |
| EPS Basic Continuous Ops | -3.50 | -12.18 | -17.19 | -17.89 | -17.82 |
| EPS Diluted Total Ops | -3.50 | -12.31 | -17.01 | -18.02 | -17.82 |
| EPS Diluted Continuous Ops | -3.50 | -12.18 | -17.19 | -17.89 | -17.82 |
| EPS Diluted Before Non-Recurring Items | -3.50 | -12.31 | -32.73 | -9.91 | -9.31 |
| EBITDA(a) | $-5,744 | $-6,484 | $-9,350 | $-9,750 | $-9,898 |